Search

everythinglearnresearchcommunity

for

Search:↓

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Dutasteride may protect the brain in early Parkinson's disease.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Some herbs show promise as antiandrogenic agents.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Finasteride helps hair growth by reducing DHT levels.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Differences in enzyme activity and androgen receptors in hair follicles may explain why hair loss appears differently in men and women.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Hair follicles convert androgens, affecting hair loss patterns.

Finasteride helps treat hair loss by blocking enzyme activity.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.